Arrowhead Pharmaceuticals: Stifel cuts target price to $96 from $104
ARWR•Stifel cut its target price for Arrowhead Pharmaceuticals to $96 from $104.
Related News
Charles Schwab October core net new assets rise 50% to $66.5 billion
SCHW•
US Treasury Secretary Bessent optimistic on trade deals with Canada, Mexico
SPY•
Liftoff Mobile: Wells Fargo raises target price to $27 from $21
LFTO•
Ross Stores: Wells Fargo cuts target price to $242 from $248
ROST•
Eagle Point Income Company Q3 net income $4.6 million
EIC•